VIVS — VivoSim Labs Cashflow Statement
0.000.00%
Last trade - 00:00- $4.08m
- -$7.23m
- $0.14m
- 13
- 31
- 25
- 11
Annual cashflow statement for VivoSim Labs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.8 | -11.4 | -17.3 | -14.7 | -2.49 |
| Depreciation | |||||
| Non-Cash Items | 5.58 | 2.26 | 2.25 | 1.35 | -8.28 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.11 | 0.597 | 2.31 | -1.62 | 1.04 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.3 | -8.45 | -12.4 | -14.7 | -9.46 |
| Capital Expenditures | -0.405 | -0.409 | -0.396 | -0.042 | -0.013 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.012 | 0 | -0.57 | 0.858 | 9.04 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.393 | -0.409 | -0.966 | 0.816 | 9.03 |
| Financing Cash Flow Items | -0.004 | -0.046 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 23.8 | 0.205 | 0 | 1.44 | 8.85 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.1 | -8.66 | -13.4 | -12.4 | 8.41 |